197 related articles for article (PubMed ID: 6244924)
1. Receptor-binding activity of highly purified bovine luteinizing hormone and thyrotropin, and their subunits.
Williams JF; Davies TF; Catt KJ; Pierce JG
Endocrinology; 1980 May; 106(5):1353-9. PubMed ID: 6244924
[TBL] [Abstract][Full Text] [Related]
2. Binding of bovine thyrotropin to receptors in rat testis and its interaction with gonadotropins.
Amir SM; Sullivan RC; Ingbar SH
Endocrinology; 1978 Jul; 103(1):101-11. PubMed ID: 217636
[TBL] [Abstract][Full Text] [Related]
3. Purification and properties of an Indian major carp (Cirrhinus mrigala, Ham.) pituitary thyrotropin.
Bandyopadhyay S; Bhattacharya S
Gen Comp Endocrinol; 1993 May; 90(2):192-204. PubMed ID: 8319876
[TBL] [Abstract][Full Text] [Related]
4. Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase.
Lefort GP; Amr S; Carayon P; Nisula BC
Endocrinology; 1984 Mar; 114(3):1005-11. PubMed ID: 6321134
[TBL] [Abstract][Full Text] [Related]
5. The contribution of subunits of thyroid stimulating hormone to the binding and biological activity of thyrotropin.
Wolff J; Winand RJ; Kohn LD
Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3460-4. PubMed ID: 4372620
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a bioeffective monoclonal antibody against thyrotropin beta-subunit.
Hill BL; Lustbader JW; Erlanger BF
Endocrinology; 1987 Feb; 120(2):574-81. PubMed ID: 2433128
[TBL] [Abstract][Full Text] [Related]
7. Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in crude hCG that inhibit the response to thyrotropin in human thyroid membranes.
Hoermann R; Amir SM; Ingbar SH
Endocrinology; 1988 Sep; 123(3):1535-43. PubMed ID: 3402396
[TBL] [Abstract][Full Text] [Related]
8. Thyroid-stimulating activity of chorionic gonadotropin and luteinizing hormone.
Taliadouros GS; Canfield RE; Nisula BC
J Clin Endocrinol Metab; 1978 Oct; 47(4):855-60. PubMed ID: 95626
[TBL] [Abstract][Full Text] [Related]
9. Microheterogeneous forms of radioiodinated bovine thyrotropin: discrimination of different receptor-active components by gel permeation chromatography.
Stanton PG; Hearn MT
Endocrinology; 1986 Jan; 118(1):14-22. PubMed ID: 3000729
[TBL] [Abstract][Full Text] [Related]
10. Interaction of human chorionic gonadotropin and human luteinizing hormone with human thyroid membranes.
Carayon P; Lefort G; Nisula B
Endocrinology; 1980 Jun; 106(6):1907-16. PubMed ID: 6245856
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of alkylation of methionine residues on the activities of pituitary thyrotropin and lutropin.
Goverman JM; Pierce JG
J Biol Chem; 1981 Sep; 256(18):9431-5. PubMed ID: 6270085
[TBL] [Abstract][Full Text] [Related]
12. Design of a long-lived thyrotropin antagonist from derivatives of human chorionic gonadotropin.
Hoermann R; Amir SM; Nomura T; Ingbar SH
Endocrinology; 1989 Jan; 124(1):223-32. PubMed ID: 2462487
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the presence of luteinizing hormone/human chorionic gonadotropin-binding sites in the porcine uterus.
Ziecik AJ; Stanchev PD; Tilton JE
Endocrinology; 1986 Sep; 119(3):1159-63. PubMed ID: 3015568
[TBL] [Abstract][Full Text] [Related]
14. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.
Clark OH; Gerend PL; Goretzki P; Nissenson RA
J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132
[TBL] [Abstract][Full Text] [Related]
16. Activities of deglycosylated thyrotropin at the thyroid membrane receptor-adenylate cyclase system.
Amr S; Menezez-Ferreira M; Shimohigashi Y; Chen HC; Nisula B; Weintraub BD
J Endocrinol Invest; 1985 Dec; 8(6):537-41. PubMed ID: 3009595
[TBL] [Abstract][Full Text] [Related]
17. Polyphloretin phosphate, an antagonist of thyrotropin action: evidence for an interaction with the hormone rather than the receptor.
Amir SM; Kasagi K; Corretti M; Blank M; Ingbar SH
Endocrinology; 1985 Sep; 117(3):860-8. PubMed ID: 2990874
[TBL] [Abstract][Full Text] [Related]
18. Potent thyrotropic activity of human chorionic gonadotropin variants in terms of 125I incorporation and de novo synthesized thyroid hormone release in human thyroid follicles.
Yamazaki K; Sato K; Shizume K; Kanaji Y; Ito Y; Obara T; Nakagawa T; Koizumi T; Nishimura R
J Clin Endocrinol Metab; 1995 Feb; 80(2):473-9. PubMed ID: 7852507
[TBL] [Abstract][Full Text] [Related]
19. Receptor-specific activity of heteromeric thyrotropin (TSH) analogs: development of synthetic TSH antagonists.
Sheehan MT; Morbeck DE; Bergert ER; McCormick DJ; Milius RP; Morris JC
Pept Res; 1995; 8(5):264-71. PubMed ID: 8589548
[TBL] [Abstract][Full Text] [Related]
20. Doubly radioiodinated luteinizing hormone: preparation and characterization.
Sharp SB; Pierce JG
Endocrinology; 1981 Oct; 109(4):1052-60. PubMed ID: 6269829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
